Electra is headquartered at:
230 E Grand Avenue, Suite S-100
South San Francisco, California 94080
(888) 743-2290
Electra was founded and commenced operations as a wholly-owned subsidiary of Star Therapeutics LLC (Star) in October 2018. In June 2023, the company spun out from Star, resulting in Star no longer being our parent company or otherwise holding any shares in us.
Electra's common stock began trading on The NASDAQ Global Select Market on September 18, 2026.
Electra’s fiscal year ends on December 31st.
Electra is traded on the NASDAQ Global Select Market under the ticker symbol “ETRA.”
Computershare Trust Company, N.A.
150 Royall Street, Suite 101
Canton, MA 02021
www.computershare.com
Ernst & Young LLP
303 Almaden Boulevard
San Jose, CA 95110
(408) 947-5500
284825 106
Currently, Electra does not pay dividends or offer a dividend reinvestment program.
Electra’s press release archives can be viewed here.
Electra’s SEC filings can be viewed here.
You can submit queries to Electra’s investor relations department by contacting IR@electra-therapeutics.com.